Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Technetium-99m glucoheptonate as a brain-scanning agent

Journal Article · · J. Nucl. Med.; (United States)
OSTI ID:5265261
Of importance is proposed mechanism that TcGH functions as a substrate for the highly metabolic brain tumor tissue, which results in an enhanced lesion uptake. Significant concentration of Tc chelates in lesions may be related in part to the increased metabolic activity of abnormal tissue. Mechanisms such as enhanced blood clearance, effective penetration of the blood/brain barrier, tissue binding, and other factors, however, must be considered. We have recently analyzed 800 consecutive brain scans using TcGH, and have found the tumor detection rate to be 94%. The detection rate for infarction was slightly greater than 50% within the first week after insult, and increased to 75% after the first week. When a flow study was included, the detection rate for all infarcts was further increased to 90% for the detection of brain tumors TcGH offers certain advantages over TcO/sub 4//sup -/.
Research Organization:
Cedars-Sinai Medical Center, Los Angeles
OSTI ID:
5265261
Journal Information:
J. Nucl. Med.; (United States), Journal Name: J. Nucl. Med.; (United States) Vol. 18:10; ISSN JNMEA
Country of Publication:
United States
Language:
English